Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
South Korea flag South Korea · Delayed Price · Currency is KRW
973.00
0.00 (0.00%)
At close: Jun 26, 2025, 3:30 PM KST

KRX:002210 Revenue

In the year 2011, Dong Sung Bio Pharm.Co.,Ltd. had annual revenue of 78.44B KRW with 9.06% growth. Dong Sung Bio Pharm.Co.,Ltd. had revenue of 18.57B in the quarter ending June 30, 2013, a decrease of -0.97%.

Revenue
78.44B
Revenue Growth
+13.99%
P/S Ratio
0.81
Revenue / Employee
270.49M
Employees
290
Market Cap
63.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 201178.44B6.52B9.06%
Dec 31, 201071.93B3.20B4.66%
Dec 31, 200968.72B6.49B10.43%
Dec 31, 200862.23B1.91B3.17%
Dec 31, 200760.32B-2.61B-4.15%
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
Peptron 4.30B
Revenue Rankings